Custodis Florian, Laufs Ulrich
Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes Homburg / Saar.
Dtsch Med Wochenschr. 2015 May;140(10):761-4. doi: 10.1055/s-0041-102254. Epub 2015 May 13.
The term "LDL-Hypothesis" is frequently used to describe the association between LDL cholesterol (LDL-C) and cardiovascular outcomes. In the light of recent results of randomized trials the question arises whether the term hypothesis is still adequate. Considering the causal importance of LDL for the pathogenesis of atherosclerosis, epidemiological evidence and the clear genetic association of LDL-C with cardiovascular risk as well as the large statin trials and the reduction of events by a non-statin intervention in the IMPROVE-IT study, the term "hypothesis" appears to be outdated and should be replaced by "LDL-causality".
术语“低密度脂蛋白假说”经常被用来描述低密度脂蛋白胆固醇(LDL-C)与心血管疾病转归之间的关联。鉴于近期随机试验的结果,“假说”这一术语是否仍然适用就成了问题。考虑到低密度脂蛋白在动脉粥样硬化发病机制中的因果重要性、流行病学证据、LDL-C与心血管风险之间明确的遗传关联,以及大型他汀类药物试验和IMPROVE-IT研究中一项非他汀类干预措施带来的事件减少情况,“假说”这一术语似乎已过时,应被“LDL因果关系”所取代。